Parkman Healthcare Partners LLC Sage Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$40.65 - $59.54 $1.82 Million - $2.66 Million
44,712 Added 176.58%
70,033 $3.29 Million
Q1 2023

May 12, 2023
BUY
$37.27 - $46.57 $943,713 - $1.18 Million
25,321 New
25,321 $1.06 Million
Q2 2020

Aug 13, 2020
SELL
$25.95 - $43.15 $1.95 Million - $3.24 Million
-75,000 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$26.15 - $77.24 $1.96 Million - $5.79 Million
75,000 New
75,000 $2.15 Million

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email